Bladder Health Bladder Health Medications

This category covers medicines that calm an overactive bladder and ease urinary urgency, frequency and leakage. They work alongside bladder-training and fluid habits.

Medicines in the Bladder Health category

Vesicare

Solifenacin

5 · 10mg

Formulated for overactive bladder syndrome to mitigate urgency symptoms.

From $1.86 / tablet View

Myrbetriq

Mirabegron

50mg

Product formulated to relieve overactive bladder symptoms and designed to support bladder control by relaxing the bladder muscle.

From $2.99 / tablet View

Ditropan

Oxybutynin

2.5 · 5mg

Utilized to alleviate bladder spasms, intended to address frequency and incontinence.

From $0.70 / tablet View

Detrol

Tolterodine

1 · 2mg

Utilized to manage overactive bladder symptoms to support bladder control.

From $1.50 / tablet View

Urispas

Flavoxate

200mg

Formulated to mitigate bladder spasms and frequency.

From $1.19 / tablet View

Elmiron

Pentosan Polysulfate

100mg

Product utilized to address interstitial cystitis and indicated to support the bladder lining by reducing pain and discomfort.

From $4.25 / tablet View

Nocdurna

Desmopressin

0.2mg

Indicated to manage nocturia to alleviate nocturnal polyuria symptoms.

From $4.16 / tablet View

Oxytrol

Oxybutynin

5mg

Intended to manage overactive bladder symptoms to support bladder function.

From $1.10 / tablet View

Enablex

Darifenacin

7.5mg

Indicated for bladder control, formulated to reduce urgency and target muscle contractions to support normal bladder function in patients.

From $2.55 / tablet View

Urecholine

Bethanechol

25mg

Indicated for urinary retention, utilized to target bladder muscle receptors and support enhanced emptying in post-operative or neurogenic conditions.

From $1.36 / tablet View

What’s in this category

Conditions it covers

These medicines are used for overactive bladder, urinary urgency and urinary incontinence.

Bladder Health in Asia

Overactive bladder and urinary symptoms become more common with age, and as populations in Japan, South Korea and across Asia grow older, demand for treatment keeps rising. These are common, manageable conditions, and effective treatments are widely used throughout the region.